Deriving actionable strategies to enhance cancer immunotherapy response
Deriving actionable strategies to enhance cancer immunotherapy response
批准号:
nhmrc : 1148680
负责人:
Dr Miles Andrews
金额:
$29.82万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Early Career Fellowships
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 2021-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cancer immunotherapy is an increasingly common treatment used to treat several types of advanced cancers. Whilst it can be dramatically effective in a minority of patients, many patients do not respond to the treatment and our ability to predict who will not benefit is limited. This project aims to study distinct aspects of tumour immunology in patients receiving immunotherapy treatments in order to identify better predictors and more widely-effective immunotherapy treatment strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deriving actionable strategies to enhance cancer immunotherapy response
-
批准号:nhmrc : GNT1148680
-
项目类别:Early Career Fellowships
-
资助金额:$43.88万
-
财政年份:2018
-
负责人:Dr Miles Andrews
-
依托单位:
Characterisation of the role of mesenchymal phenotypes and EGFR in treatment-resistant melanoma.
-
批准号:nhmrc : GNT1055456
-
项目类别:Postgraduate Scholarships
-
资助金额:$11.32万
-
财政年份:2013
-
负责人:Dr Miles Andrews
-
依托单位:
Non-mutational phenotypic evolution in metastatic melanoma: the role of the epidermal growth factor receptor and epithelial-mesenchymal transition-like processes in treatment resistance.
-
批准号:nhmrc : 1055456
-
项目类别:Postgraduate Scholarships
-
资助金额:$9.4万
-
财政年份:2013
-
负责人:Dr Miles Andrews
-
依托单位:
海外基金